Evelo Biosciences EVLO Stock
Evelo Biosciences Price Chart
Evelo Biosciences EVLO Financial and Trading Overview
| Evelo Biosciences stock price | 0.05 USD |
| Previous Close | 0.1 USD |
| Open | 0.1 USD |
| Bid | 0.32 USD x 3200 |
| Ask | 0.32 USD x 1400 |
| Day's Range | 0.08 - 0.11 USD |
| 52 Week Range | 0.02 - 3.29 USD |
| Volume | 18.68M USD |
| Avg. Volume | 4.47M USD |
| Market Cap | 9.28M USD |
| Beta (5Y Monthly) | 1.263028 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -15.64 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.03 USD |
EVLO Valuation Measures
| Enterprise Value | 34.27M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.11513889 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.334 |
Trading Information
Evelo Biosciences Stock Price History
| Beta (5Y Monthly) | 1.263028 |
| 52-Week Change | -95.38% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.29 USD |
| 52 Week Low | 0.02 USD |
| 50-Day Moving Average | 0.14 USD |
| 200-Day Moving Average | 1.14 USD |
EVLO Share Statistics
| Avg. Volume (3 month) | 4.47M USD |
| Avg. Daily Volume (10-Days) | 3.89M USD |
| Shares Outstanding | 111.99M |
| Float | 60.61M |
| Short Ratio | 2.75 |
| % Held by Insiders | 0.12% |
| % Held by Institutions | 83.65% |
| Shares Short | 3.08M |
| Short % of Float | 6.85% |
| Short % of Shares Outstanding | 2.75% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -129.75% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -102640000 USD |
| Net Income Avi to Common (ttm) | -110007000 USD |
| Diluted EPS (ttm) | -1.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 27.47M USD |
| Total Cash Per Share (mrq) | 0.25 USD |
| Total Debt (mrq) | 50.7M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.525 |
| Book Value Per Share (mrq) | -0.247 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -92579000 USD |
| Levered Free Cash Flow (ttm) | -53932000 USD |
Profile of Evelo Biosciences
| Country | United States |
| State | MA |
| City | Cambridge |
| Address | 620 Memorial Drive |
| ZIP | 02139 |
| Phone | 617 577 0300 |
| Website | https://www.evelobio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 66 |
Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Q&A For Evelo Biosciences Stock
What is a current EVLO stock price?
Evelo Biosciences EVLO stock price today per share is 0.05 USD.
How to purchase Evelo Biosciences stock?
You can buy EVLO shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Evelo Biosciences?
The stock symbol or ticker of Evelo Biosciences is EVLO.
Which industry does the Evelo Biosciences company belong to?
The Evelo Biosciences industry is Biotechnology.
How many shares does Evelo Biosciences have in circulation?
The max supply of Evelo Biosciences shares is 18.98M.
What is Evelo Biosciences Price to Earnings Ratio (PE Ratio)?
Evelo Biosciences PE Ratio is now.
What was Evelo Biosciences earnings per share over the trailing 12 months (TTM)?
Evelo Biosciences EPS is -15.64 USD over the trailing 12 months.
Which sector does the Evelo Biosciences company belong to?
The Evelo Biosciences sector is Healthcare.
Evelo Biosciences EVLO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}